Bevacizumab and Retinal Ischemia

Ophthalmology

Volumn 114, Issue 11, 2007, Pages

  Neubauer, Aljoscha S ^a   Kook, Daniel ^a   Haritoglou, Christos ^a   Priglinger, Siegfried G ^a   Kampik, Anselm ^a   Ulbig, Michael W ^a   Ceklic, Lala ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

DIABETIC RETINOPATHY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; LETTER; METABOLIC REGULATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; RETINA ISCHEMIA; SCANNING LASER OPHTHALMOSCOPY; STATISTICAL SIGNIFICANCE; VISUAL ACUITY;

EID: 35548954255     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.05.057     Document Type: Letter

References (5)

1. Haritoglou C., Kook D., Neubauer A., et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26 (2006) 999-1005
2. Avery R.L., Pearlman J., Pieramici D.J., et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 (2006) 1695-1705 e6
3. Manivannan A., Plskova J., Farrow A., et al. Ultra-wide-field fluorescein angiography of the ocular fundus. Am J Ophthalmol 140 (2005) 525-527
4. Takahashi K., Kishi S., Muraoka K., and Shimizu K. Reperfusion of occluded capillary beds in diabetic retinopathy. Am J Ophthalmol 126 (1998) 791-797
5. Ziemssen F., Bartz-Schmidt K.U., and Grisanti S. (Side) effects of VEGF inhibition. [in German]. Ophthalmologe 103 (2006) 484-492